Update on low density lipoprotein receptor mutations

Current Opinion in Lipidology

Volumn 9, Issue 2, 1998, Pages 141-147

  Soutar, Anne K ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN RECEPTOR;

CLINICAL FEATURE; CLINICAL PRACTICE; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HETEROZYGOTE; HUMAN; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW;

DATABASES, FACTUAL; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, LDL;

EID: 0031942101     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199804000-00011     Document Type: Review

References (59)

1. Goldstein JL, Hobbs H, Brown MS. Familial hypercholesterolaemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (editors). The metabolic basis of inherited diseases. Vol. II 7th ed. New York: McGraw-Hill; 1995. pp. 1981-2030.
2. Myant NB, Gallagher JJ, Knight BL, McCarthy SN, Frostegard J, Nilsson J, et al. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function. Arterioscler Thromb 1991; 11:691-703.
3. Sun XM, Patel DD, Webb JC, Knight BL, Fam LM, Cai HJ, et al. Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler Thromb 1994; 14:85-94.
4. Jensen HK, Jensen LG, Hansen PS, Faergeman O, Gregersen N. High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing. Clin Chem 1996; 42:1400-1446.
5. Humphries SE, Gudnason V, Whittall R, Day I. Single strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia. Clin Chem 1997; 43:427-435.
6. Nissen H, Guldberg P, Hansen AB, Petersen NE, Horder M. Clinically applicable mutation screening in familial hypercholesterolemia. Hum Mutat 1996; 8:168-177.
7. Lombardi P, Sijbrands EJ, van DGK, Smelt AH, Kastelein JJ, Frants RR, et al. Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing. J Lipid Res 1995; 36:860-867.
8. Peeters AV, Vangaal LF, Duplessis L, Lombardi M, Havekes LM, Kotze MJ, et al. Mutational and genetic origin of LDL-receptor gene mutations detected in both Belgian and Dutch familial hypercholesterolemics. Hum Genet 1997; 100:266-270.
9. Vohl MC, Moorjani S, Roy M, Gaudet D, Torres AL, Minnich A, et al. Geographic distribution of French Canadian low density lipoprotein receptor gene mutations in the Province of Quebec. Clin Genet 1997; 52:1-6.
10. Descamps O, Hondekijn JC, Van AP, Deslypere JP, Heller FR. High prevalence of a novel mutation in the exon 4 of the low-density lipoprotein receptor gene causing familial hypercholesterolemia in Belgium. Clin Genet 1997; 51:303-308.
11. Whittall R, Gudnason V, Weavind GP, Day LB, Humphries SE, Day IN, et al. Utilities for high throughput use of the single strand conformational polymorphism method: screening of 791 patients with familial hypercholesterolaemia for mutations in exon 3 of the low density lipoprotein receptor gene. J Med Genet 1995; 32:509-515.
12. Vuorio AF, Paulin L, Turtola H, Kontula K. Deletions of the low density lipoprotein receptor gene underlying familial hypercholesterolaemia: screening by polymerase chain reaction using pooled DNA and blood samples. Mol Cell Probes 1997; 11:65-70.
13. Chae JJ, Park YB, Kim SH, Hong SS, Song GJ, Han KH, et al. Two partial deletion mutations involving the same alu sequence within intron 8 of the LDL-receptor gene in Korean patients with familial hypercholesterolemia. Hum Genet 1997; 99:155-163.
14. Jensen LG, Jensen HK, Heath F, Eiberg H, Kjeldsen M, Faergeman O. et al. Allele specific measurement of low density lipoprotein receptor transcript levels. Hum Mutat 1996; 8:126-133.
15. Jensen HK, Jensen LG, Heath F, Melsen F, Hansen PS, Meinertz H, et al. Phenotypic characterization of a patient homozygous for the D558N LDL receptor gene mutation. Clin Genet 1996; 50:388-392.
16. Chan PC, Jones C, Lafreniere R, Parsons HA. Surface expression of low density lipoprotein receptor in EBV-transformed lymphocytes: characterization and use for studying familial hypercholesterolaemia. Atherosclerosis 1997; 131:149-160.
17. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1:445-466.
18. Varret M, Rabes JP, Collod BG, Junien C, Boleau C, Beroud C, et al. Software and database for the analysis of mutations in the human LDL receptor gene. Nucl Acids Res 1997; 25:172-180.
19. Day I, Whittall RA, Odell SD, Haddad L, Bolla MK, Gudnason V, et al. Spectrum of LDL-receptor gene mutations in heterozygous familial hypercholesterolemia. Hum Mutat 1997; 10:116-127.
20. Koivisto UM, Palvimo JJ, Janne OA, Kontula K. A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sc USA 1994; 91:10526-10530.
21. Sun XM, Neuwirth C, Wade DP, Knight BL, Soutar AK. A mutation (T-45C) in the promoter region of the low-density-lipoprotein (LDL)-receptor gene is associated with a mild clinical phenotype in a patient with heterozygous familial hypercholesterolaemia (FH). Hum Mol Genet 1995; 4:2125-2129.
22. Kotze MJ, Loubser O, Thiart R, Devilliers J, Langenhoven E, Theart L, et al. CpG hotspot mutations at the LDL-receptor locus are a frequent cause of familial hypercholesterolaemia among South African Indians. Clin Genet 1997; 51:394-398.
23. Lombardi P, Defesche JC, Kamerling S, Kastelein J, Havekes LM. A novel mutation M21V in exon 1 of the low density lipoprotein receptor gene causing familial hypercholesterolemia. Clin Genet 1937; 51:430-431.
24. Lombardi P, Defesche JC, Kamerling SW, Kastelein JJ, Havekes LM. A novel V415A mutation in exon 9 of the low density lipoprotein receptor gene causing familial hypercholesterolemia. Clin Genet 1997; 51:286-287.
25. Assouline L, Leitersdorf E, Lambert M, Reshef A, Feoli FJ, Levy E. Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: mutational analysis and biochemical studies. Hum Mutat 1997; 9:555-562.
26. Langenhoven E, Warnich L, Thiart R, Rubinsztein DC, Van der Westhuyzen D, Marais AD, et al. Two novel point mutations causing receptor-negative familial hypercholesterolemia in a South African Indian homozygote. Atherosclerosis 1996; 125:111-119.
27. Nissen H, Hansen AB, Guldberg P, Petersen NE, Hansen TS, Horder M. Detection and characterization of a novel splice mutation in the LDL receptor intron 12 resulting in two different mutant mRNA variants. Atherosclerosis 1997; 128:75-83.
28. Koivisto UM, Kontula K. A novel deletion/inversion mutation in the low-density lipoprotein receptor gene as a cause of heterozygous familial hypercholesterolemia. Hum Mutat 1996; 8:326-332
29. Reshef A, Nissen H, Triger L, Hensen TS, Eliav O, Schurr D, et al. Molecular genetics of familial hypercholeslerolemia in Israel. Hum Genet 1996; 98:581-586.
30. Webb JC, Patel DD, Shoulders CC, Knight BL, Soutar A. Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL) receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism. Hum Mol Genet 1996; 5:1325-1331.
31. Kotze MJ, Thiart R, Loubser O, De Villiers JNP, Santos M, Vargas MA, et al. Mutation analysis reveals an insertional hotspot in exon 4 of the LDL receptor gene. Hum Genet 1396; 98:476-478.
32. Kotze MJ, De Villiers JNP, Loubser O, Thiart R, Scholtz CL, Raal FJ. A double mutant LDL receptor allele in a Cypriot family with heterozygous familial hypercholesterolemia. Hum Genet 1997; 100:101-103.
33. Jensen HK, Jensen TG, Faergeman O, Jensen LG, Andresen BS, Corydon MJ, et al. Two mutations in the same low-density lipoprotein receptor allele act in synergy to reduce receptor function in heterozygous familial hypercholesterolemia. Hum Mutat 1997; 9:437-444.
34. Vuorio AF, Turtola H, Kontula K. A novel point mutation (Pro84 +Ser) of the low density lipoprotein receptor gene in a family with moderate hypercholesterolemia. Clin Genet 1997; 51:191-195.
35. Leren TP, Tonstad S, Gundersen KE, Bakken KS, Rodningen OK. Sundvold H, et al. Molecular genetics of familial hypercholesterolaemia in Norway. J Int Med 1997; 241:185-194.
36. Mavroidis N, Traeger SJ, Kanavakis E, Drogari E, Matsaniotis N, Humphries SE, et al. A high incidence of mutations in exon 6 of the low-density lipoprotein receptor gene in Greek familial hypercholesterolemia patients, including a novel mutation. Hum Mutat 1997; 9:274-276.
37. Koivisto UM, Gylling H, Mietlinen TA, Kontula K. Familial moderate hypercholesterolemia caused by Asp235Glu mutation of the LDL receptor gene and co occurrence of a de novo deletion of the LDL receptor gene in the same family. Arterioscler Thrombosis Vasc Biol 1997; 17:1392-1399.
38. Gudnason V, Sigurdsson G, Nissen H, Humphries SE. Common founder mutation in the LDL-receptor gene causing familial hypercholesterolaemia in the Icelandic population. Hum Mutat 1997; 10:36-44.
39. Jensen HK, Holst H, Jensen LG, Jorgensen MM, Andreasen PH, Jensen TG, et al. A common W556S mutation in the LDL receptor gene of Danish patients with familial hypercholesterolemia encodes a transport-defective protein. Atherosclerosis 1997; 131:67-72.
40. Sun X-M, Patel DD, Knight B, Soutar AK. Comparison of the genetic defect with LDL receptor activity in cultured cells from patients with a clinical diagnosis of heterozygous familial hypercholesterolaemia. Arterioscler Thromb Vasc Biol 1997, 17:3092-3101.
41. Loux N, Saint JB, Collod G, Dairou F, Benlian P, Truffert J, et al. Screening for new mutations in the LDL receptor gene in seven French familial hypercholesterolemia families by the single strand conformation polymorphism method. Hum Mutat 1992; 1:325-332
42. Lombardi P, Sijbrands EJ, Kamerling S, Leuven JA, Havekes LM. The T7051 mutation of the low density lipoprotein receptor gene (FH Paris-9) does not cause familial hypercholesterolemia. Hum Genet 1997; 99:106-107.
43. Lombardi P, Kamerling S, Defesche JC, Kastelein J, Havekes LM. Identification of a double mutation in the low density lipoprotein receptor gene causing familial hypercholesterolemia. Clin Genet 1996; 50:525-526.
44. Day IN, Haddad L, O'Dell SD, Day LB, Whittall RA, Humphries SE. Identification of a common low density lipoprotein receptor mutation (R329X) in the south of England: complete linkage disequilibrium with an allele of microsatellite D19S394. J Med Genet 1997; 34:111-116.
45. Baron H, Fung S, Aydin A, Bahring S, Luft FC, Schuster H. Oligonucleotide assay (ola) for the diagnosis of familial hypercholesterolemia. Nature Biotech 1996; 14:1279-1282.
46. Webb JC, Sun X, McCarthy SN, Neuwirth C, Thompson GR, Knight BL, et al. Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom. J Lipid Res 1996; 37:368-381.
47. Steyn K, Goldberg YP, Kotze MJ, Steyn M, Swanepoel AS, Fourie JM, et al. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations. Hum Genet 1996; 98:479-484.
48. Soutar AK. Familial hypercholesterolaemia. In: Humphries SE, Malcolm S (editors). From genotype to phenotype. Oxford. UK: BIOS Scientific Publishers Ltd; 1994. pp. 83-109.
49. Betard C, Kessling AM, Roy M, Davignon J. Influence of genetic variability in the non deletion LDL-receptor allele on phenotypic variation in French-Canadian familial hypercholesterolemia heterozygotes sharing a 'null' LDL-receptor gene detect. Atherosclerosis 1996; 119:43-55.
50. Gudnason V, Day IN, Humphries SE. Use of the single strand conformation polymorphism method for rapid screening for mutations in the low density lipoprotein receptor gene in patients with familial hypercholesterolemia: effect on plasma lipid levels of different classes of mutations. Z Gastroenterol 1996; 3:6-8.
51. Vohl MC, Gaudet D, Moorjani S, Tremblay G, Perron P, Gagne C, et al. Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia. Eur J Clin Invest 1997; 27:366-373.
52. Jensen HK, Jensen LG, Hansen PS, Faergeman O, Gregersen N. The Trp23Stop and Trp66Gly mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in Denmark. Atherosclerosis 1996; 120:57-65.
53. Torres AL, Moorjani S, Vohl MC, Gagne C, Lamarche B, Brun LD, et al. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations. Atherosclerosis 1996; 126:163-171.
54. Levy E, Minnich A, Cacan SL, Thibault L, Giroux LM, Davignon J, et al. Association of an exon 3 mutation (Trp66 → Gly) of the LDL receptor with variable expression of familial hypercholesterolemia in a French Canadian family. Biochem Mol Med 1997; 60:59-69.
55. Haraki T, Inazu A, Yagi K, Kajinami K, Koizumi J, Mabuchi H. Clinical characteristics of double heterozygotes with familial hypercholesterolemia and cholesteryl ester transfer protein deficiency. Atherosclerosis 1997; 132:229-236.
56. Feussner G, Dobmeyer J, Nissen H, Hansen TS. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia. Am J Med Genet 1996; 65:149-154.
57. Benlian P, de Gennes JL, Dairou F, Hermelin B, Ginon I, Villain E, et al. Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B-100. Hum Mutat 1996; 7:340-345.
58. Nissen H, Hansen AB, Guldberg P, Petersen NE, Larsen ML, Haghfelt T, et al. Phenotypic presentation of the FH-Cincinnati type 5 low density lipoprotein receptor mutation. Scand J Clin Lab Invest 1996; 56:75-85.
59. Tonstad S. Familial hypercholesterolaemia: a pilot study of parents' and children's concerns. Acta Paediatr 1996; 85:1307-1313.